Results 191 to 200 of about 213,470 (338)

CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination. [PDF]

Diabetes Obes Metab
Pan Q, Ai W, Chen Y, Shen Z, Yang W, Jiang W, Guo S.   +6 more
europepmc   +1 more source

The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
Abstract A better understanding of additional mechanisms of heart failure (HF) progression may allow a different and more complete phenotyping of the disease and identification of novel therapeutic targets. Persistent latent myocardial inflammation/immune activation in HF may represent an attempt to restore tissue homeostasis in the failing heart ...
Gabriele Fragasso, Davide Stolfo, Markus S. Anker, Antoni Bayes‐Genis, Ovidiu Chioncel, Stephane Heymans, Pardeep S. Jhund, Basil S. Lewis, Gary D. Lopaschuk, Lars H. Lund, Arantxa Gonzalez, Matteo Pagnesi, Gabriele Giacomo Schiattarella, Carlo Gabriele Tocchetti, Peter van der Meer, Sophie Van Linthout, Sven Wassmann, B. Daan Westenbrink, Marco Metra, Giuseppe M.C. Rosano, Gianluigi Savarese   +20 more
wiley   +1 more source

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes. [PDF]

Sci Rep
Goodman J, Schain M, Di Stefano G, Lupson V, Horn T, Hill M, Manavaki R, Fryer TD, Bumanlag-Amis E, Jalaludeen N, Jermutus L, Johansson E, Heurling K, Haraldsson H, Evans M, Cheriyan J, Johansson L, Ambery P, Wilkinson IB.   +18 more
europepmc   +1 more source

Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)

European Journal of Heart Failure, EarlyView.
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz, Juel Maalouli Schaar, Katharina R. Welker, Lucas Lauder, Felix Götzinger, Ingrid Kindermann, Martin Schulz, Michael Böhm, Markus R. Meyer, Felix Mahfoud   +9 more
wiley   +1 more source

Assessing the Knowledge of Diabetic Patients About Glucagon Use in Hypoglycemia: A Cross-Sectional Study in Riyadh, Saudi Arabia. [PDF]

Cureus
Hussien A, Alkharasani AM, Alaboudi ZA, Alkhathran SA, Abu Suliman T, Alanazi AF, Ezzi MI, Almajid GJ, Almutleeg ZH, Msawa MA.   +9 more
europepmc   +1 more source

The physiological effect of glucagon on fat-mobilisation [PDF]

, 1966
Pierre Lefèbvre
openalex   +1 more source

Oat Bran Supplementation Improves Glucose Metabolism, Food Addiction, and Gut Microbiota in Rats With High‐Fat Diet‐Induced Obesity

Food Frontiers, EarlyView.
ABSTRACT Oat bran (OB), a byproduct of the oat milling process, is a nutrient‐dense cereal cultivated in cool, dry mountainous regions and is known for its potential health benefits. To explore its obesity‐alleviating effects and the underlying mechanisms, we examined the influence of OB on glucose metabolism, appetite‐regulating hormones, gut ...
Xue Bai, Meili Zhang, Yakun Zhang, Yuanyuan Zhang, Rui Huo, Qixin Gu, Ying Miao   +6 more
wiley   +1 more source

New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity. [PDF]

Int J Mol Sci
Dira LM, Marin LM, Popa SG, Singer CE, Cosoveanu CS, Donoiu I, Golli AL.   +6 more
europepmc   +1 more source

Effects of Glucagon on Amino Acid Transport and Utilization in the Perfused Rat Liver

, 1969
Lawrence E. Mallette, John H. Exton, C.R. Park   +2 more
openalex   +1 more source

Response to Glucagon by Subjects with Hyperinsulinism from Islet-cell Tumours [PDF]

, 1960
V. Marks
openalex   +1 more source